Neoplasm Metastasis

Search with Google Search with Bing
Information
Disease name
Neoplasm Metastasis
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03721952 Active, not recruiting N/A Facilitating Communication Study April 17, 2019 June 30, 2024
NCT03697304 Active, not recruiting Phase 2 Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours February 12, 2019 May 23, 2025
NCT04283994 Active, not recruiting N/A Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) July 26, 2021 August 1, 2025
NCT05103358 Active, not recruiting Phase 2 Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) February 15, 2022 December 31, 2025
NCT04458259 Active, not recruiting Phase 1 Study of PF-07265807 in Participants With Metastatic Solid Tumors. September 24, 2020 June 30, 2024
NCT03678883 Active, not recruiting Phase 2 9-ING-41 in Patients With Advanced Cancers January 4, 2019 November 2025
NCT05169567 Active, not recruiting Phase 3 Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer March 11, 2022 February 16, 2026
NCT05288166 Active, not recruiting Phase 3 A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) April 14, 2022 October 2027
NCT04574245 Active, not recruiting Gastric Cancer Liver Metastasis Cohort of China January 1, 2010 December 31, 2022
NCT02953717 Active, not recruiting N/A Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B) February 2016 December 2023
NCT02892305 Active, not recruiting Hepatic Resection for Metastatic Pancreatic Cancer May 18, 2018 June 30, 2027
NCT03775980 Active, not recruiting CIRSE Emprint Microwave Ablation Registry September 4, 2019 January 31, 2026
NCT03510104 Active, not recruiting Phase 1 Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors May 22, 2018 July 2024
NCT00001576 Completed Phase 1 A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver July 1997 March 2002
NCT00001587 Completed Phase 1 A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver September 1997 March 2001
NCT00001683 Completed Phase 1 A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer October 1997 August 2003
NCT00001685 Completed Phase 2 Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase November 1997 September 2000
NCT00001705 Completed Phase 2 Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence July 1998 June 2001
NCT00001832 Completed Phase 2 Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma August 1999 May 2010
NCT00001835 Completed Phase 1 Oxaliplatin in Cancer Patients With Impaired Kidney Function September 1999 December 2001
NCT00001165 Completed Phase 2 Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas September 1978 August 2003
NCT00004988 Completed Phase 1 Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria March 2000 October 2002
NCT05495529 Completed Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors January 1, 2013 May 11, 2022
NCT00029900 Completed Phase 1 ADI-PEG in Patients With Metastatic Melanoma September 2001 August 2003
NCT00033878 Completed Phase 1 Study of Noni in Cancer Patients November 2001 June 2006
NCT00034346 Completed Phase 2 ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) January 2002
NCT00055562 Completed Phase 2/Phase 3 Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma January 2003 December 2004
NCT00057616 Completed Phase 3 Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma. October 1, 2002 July 15, 2005
NCT00067314 Completed Phase 2 Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy June 2003 June 2007
NCT00068068 Completed Phase 2 Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases October 2003
NCT00072865 Completed Phase 2 Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer June 2003 September 2005
NCT00075166 Completed Phase 4 Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors December 2003 November 2005
NCT00076856 Completed Phase 2 Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) March 31, 2004 March 31, 2006
NCT00083785 Completed Phase 2 Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases May 2004
NCT00094003 Completed Phase 1 Study of NS-9 in Patients With Liver Metastases September 2002
NCT04707196 Completed Phase 4 A Study of Abemaciclib in Indian Women With Advanced Breast Cancer February 22, 2021 January 9, 2023
NCT00101920 Completed Phase 2 ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) June 2003 December 2004
NCT00106613 Completed Phase 2 A Research Study for Patients With Metastatic Renal Cell Carcinoma May 1, 2003 August 1, 2004
NCT04310410 Completed Phase 1/Phase 2 Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis April 11, 2019 June 1, 2020
NCT00116506 Completed Phase 2 Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer January 2005 July 2007
NCT00119899 Completed Phase 3 Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases March 2002 June 2005
NCT04281784 Completed N/A Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) April 23, 2020 September 26, 2022
NCT04200963 Completed Phase 1 A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma December 18, 2019 July 18, 2023
NCT00123851 Completed Phase 2 Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer March 2003 August 2006
NCT00124761 Completed Phase 3 A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases December 2002 May 2009
NCT00125021 Completed Phase 2 Tarceva and Capecitabine for Pancreatic Cancer October 2003 September 2008
NCT00125034 Completed Phase 2 Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) July 2005 November 2010
NCT00125749 Completed Phase 1/Phase 2 Vaccination of Patients With Stage IV Melanoma With Dendritic Cells July 2005 June 2007
NCT03876574 Completed Phase 1 Hepatic Artery Infusion Pump for NPC Liver Metastases January 1, 2011 December 31, 2017
NCT00128297 Completed Phase 4 Pamidronate Administration in Breast Cancer Patients With Bone Metastases October 18, 2000 June 4, 2004
NCT00128310 Completed Phase 3 Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients January 18, 2001 January 24, 2008
NCT00129051 Completed Phase 1 Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases August 2001 November 2005
NCT03831243 Completed N/A A Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastases April 9, 2019 October 26, 2023
NCT00130689 Completed Phase 2 Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer July 2005 September 2010
NCT03785925 Completed Phase 2 A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer April 29, 2019 June 30, 2022
NCT00138788 Completed Phase 3 Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases February 1996 March 2007
NCT00142038 Completed Phase 2 Docetaxel and Capecitabine in Advanced Gastric Cancer March 2004 December 2007
NCT00144378 Completed Phase 3 Irinotecan Versus Only Best Supportive Care for Gastric Cancer October 2002
NCT00149201 Completed Phase 3 A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis November 2002 April 2008
NCT00165568 Completed Phase 2 Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer July 2005 October 2006
NCT00171587 Completed Phase 1/Phase 2 Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer May 2002 March 2007
NCT00171964 Completed Phase 4 Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions May 2002 December 2008
NCT00172003 Completed Phase 4 Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis September 2004 July 2009
NCT00178243 Completed Phase 1/Phase 2 Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
NCT00184275 Completed Characterization of Brain Metastases May 2005 December 2010
NCT00188864 Completed Phase 2 Dexamethasone for Palliation - Brain Metastases November 2003 January 28, 2019
NCT00190489 Completed Phase 3 A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer January 1999 May 2006
NCT00207103 Completed Phase 1 MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors September 2004 September 2008
NCT00207116 Completed Phase 1 An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma September 2005 March 2006
NCT00221702 Completed Phase 3 PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) June 2003 October 2010
NCT00227019 Completed Phase 2 Phase 2 Trial of Bevacizumab in Combination With Pemetrexed March 2006 December 2016
NCT00232726 Completed Phase 2 Clinical Study of Previously Untreated Patients With Malignant Melanoma September 2005 July 2007
NCT03698461 Completed Phase 2 Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab May 15, 2019 October 24, 2023
NCT00270491 Completed Phase 2 Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. December 2005 October 2010
NCT00271687 Completed Phase 2 A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer February 2006 November 2007
NCT00280475 Completed Phase 3 A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis January 2006 January 2013
NCT00289445 Completed Phase 1/Phase 2 Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) September 1999 March 2006
NCT00317720 Completed Phase 1/Phase 2 Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer April 2006 February 2013
NCT00319254 Completed Phase 2 Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer May 2006 February 2009
NCT00323882 Completed Phase 1/Phase 2 Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer January 2006 July 2013
NCT00327223 Completed Phase 1 Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy November 2005 October 2006
NCT00327652 Completed Phase 1 Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases October 2006
NCT00328575 Completed Phase 1 Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases October 2005 June 2011
NCT00337155 Completed Phase 2 BAY88-8223, Dose Finding Study in Patients With HRPC May 2006 December 2009
NCT00338286 Completed Phase 3 A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy March 2, 2006 January 31, 2017
NCT00339664 Completed Analyses of Human Samples Collected in Clinical Trials July 2, 2003 March 26, 2020
NCT03415126 Completed Phase 1 A Study of ASN007 in Patients With Advanced Solid Tumors January 19, 2018 June 30, 2020
NCT00374036 Completed Phase 3 Metastatic Gastric Cancer FFCD 03-07 June 2005 December 2009
NCT00375245 Completed Phase 1 Rapamycin With Grapefruit Juice for Advanced Malignancies September 2006 May 2012
NCT00377559 Completed Phase 2 Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer May 2006 July 2011
NCT03383692 Completed Phase 1 Study of DS-8201a for Participants With Advanced Solid Malignant Tumors January 12, 2018 September 11, 2023
NCT00401323 Completed Phase 2/Phase 3 Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma January 1998 June 2003
NCT00426530 Completed Phase 1 Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer February 2007 June 2010
NCT03374592 Completed N/A Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain July 7, 2014 February 21, 2018
NCT00434317 Completed Phase 4 Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases August 2005
NCT00436423 Completed Phase 2 A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer March 2006
NCT00440310 Completed Phase 3 Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases February 2007 October 2011
NCT00444678 Completed Phase 2 Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer June 1, 2004 June 1, 2015
NCT00447330 Completed Phase 2 Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma February 2007 July 2014
NCT03293849 Completed N/A A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors August 1, 2017 July 20, 2019
NCT00459654 Completed Phase 2 A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer February 2004 May 2007
NCT03142516 Completed Phase 2 FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status October 31, 2017 January 21, 2021
NCT00492830 Completed Phase 1 Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors June 2007 November 2009
NCT00511862 Completed Phase 2 TheraSphere for the Treatment of Liver Metastases January 2007 March 2011
NCT00519285 Completed Phase 3 Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer August 2007 April 2012
NCT00542048 Completed Phase 2 A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases November 2007 September 2009
NCT00545129 Completed Phase 2 A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone April 29, 2009 February 7, 2012
NCT00561470 Completed Phase 3 Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen November 2007 June 2012
NCT03092934 Completed Phase 1/Phase 2 A Study of AK-01 (LY3295668) in Solid Tumors May 29, 2017 April 20, 2020
NCT00582985 Completed Phase 1 Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer December 2007 June 2011
NCT03086096 Completed CIRSE Registry for LifePearl Microspheres February 2, 2018 April 30, 2022
NCT00633269 Completed Phase 1 Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours April 2008 October 2008
NCT00649207 Completed Phase 1 A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases March 2008 March 2013
NCT02014129 Completed Phase 1 A Study of LY2835219 in Japanese Participants With Advanced Cancer December 18, 2013 August 21, 2019
NCT00001193 Completed Phase 2 A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer November 1984 September 2000
NCT00001250 Completed Phase 2 Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial December 1989 October 2002
NCT00001269 Completed Phase 1 Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer May 1991 February 2001
NCT00001270 Completed Phase 1 Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma June 1991 March 2000
NCT00001302 Completed Phase 1 A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 September 1992 June 2002
NCT00001328 Completed Phase 1 Gene Therapy for the Treatment of Brain Tumors August 21, 1992 April 30, 2010
NCT00001417 Completed Direct Injection of Alcohol for the Treatment of Spinal Tumors June 1994 May 2002
NCT00001436 Completed Phase 1 A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma May 1995 September 2000
NCT00001440 Completed Phase 1 Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy July 1995 January 2002
NCT00001493 Completed Phase 2 Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer October 1995 June 2000
NCT00001507 Completed Phase 1 Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer July 12, 1996 June 20, 2014
NCT00001570 Completed Phase 1 A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer February 1997 January 2001
NCT01996306 Completed Phase 3 A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC December 2, 2013 June 30, 2018
NCT00710268 Completed Phase 1 Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours June 2008 November 2009
NCT02801409 Completed N/A Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery May 25, 2015 November 30, 2019
NCT00728390 Completed Phase 1 A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks December 15, 2008 January 29, 2013
NCT00731861 Completed Phase 1 Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors May 2005 August 2010
NCT00764621 Completed Phase 4 Health Economic Evaluation of Primovist-enhanced Liver MRI October 2008 November 2010
NCT02753790 Completed N/A Whole Brain Radiation Using IMRT for Patients With Brain Metastases February 2016 April 10, 2022
NCT02707510 Completed N/A A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer October 2016 March 2020
NCT00798135 Completed N/A A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer November 2008 March 2012
NCT00851084 Completed Phase 2 Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer February 2009 January 2012
NCT00904553 Completed Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases January 14, 2009 March 28, 2022
NCT02688088 Completed Phase 1 A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body March 8, 2016 January 6, 2021
NCT00920504 Completed N/A Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program June 2009 June 2011
NCT00921661 Completed Phase 1 Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer June 2009 June 2012
NCT00928226 Completed N/A Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases April 2009 December 2019
NCT00946673 Completed Phase 1 Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer June 2009 July 2015
NCT00960557 Completed Phase 1 Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden July 2009 October 2010
NCT00977639 Completed Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies February 2008 June 2009
NCT01011972 Completed Phase 1 A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors March 2010 September 2013
NCT01039649 Completed A Study to Test Lung Function After Radiation Therapy June 2009 December 2013
NCT01114958 Completed Phase 1 Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases September 3, 2009 May 17, 2013
NCT02677116 Completed Phase 1 A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer August 29, 2016 April 3, 2019
NCT02661685 Completed Phase 1 Safety Study of Adoptive Transfer of Autologous IKDC-like Cells May 2016 October 2019
NCT01198301 Completed Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy August 2010 July 2012
NCT01218542 Completed N/A Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc September 22, 2010 June 3, 2020
NCT01231022 Completed Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) August 2010 June 2013
NCT01232062 Completed Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients August 2010 October 2013
NCT01256801 Completed Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion November 2010 December 2013
NCT01307878 Completed Phase 3 New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases June 2012 June 2021
NCT01353625 Completed Phase 1 Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. April 25, 2011 March 12, 2021
NCT01373164 Completed Phase 1/Phase 2 A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer June 2011 December 2016
NCT01395056 Completed Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients July 2011 June 2015
NCT02642185 Completed Microwave Ablation Versus Resection for Resectable Colorectal Liver Metastases December 1, 2015 January 1, 2022
NCT01441596 Completed Phase 2 Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases October 2011 August 2014
NCT02622841 Completed Phase 1/Phase 2 Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases June 2015 April 2017
NCT02583828 Completed N/A Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients June 2015 December 2021
NCT01461265 Completed Phase 1 Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases November 2011 April 2015
NCT02511678 Completed N/A Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases February 15, 2016 March 12, 2018
NCT02456285 Completed Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pathways May 20, 2015 April 30, 2017
NCT02411591 Completed Phase 1 A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC) June 4, 2015 May 28, 2019
NCT01594892 Completed N/A Fractionated Radiosurgery for Painful Spinal Metastases April 2012 July 2017
NCT02406170 Completed Phase 1/Phase 2 Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma April 2015 October 2019
NCT01695005 Completed Phase 1 A Study of LY3039478 in Participants With Advanced Cancer October 2012 June 26, 2018
NCT01696565 Completed Phase 1/Phase 2 PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy December 2001 October 2003
NCT01711684 Completed Phase 1 Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP) October 16, 2012 June 22, 2015
NCT01722825 Completed Phase 1 Study of LY2157299 in Japanese Participants With Cancer November 2012 June 2014
NCT01736813 Completed CCR5-blockade in Metastatic Colorectal Cancer November 2012 September 2014
NCT01737450 Completed Phase 2 Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive January 2013 March 2019
NCT02374411 Completed Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients September 2014 March 2015
NCT02265536 Completed Phase 1 A Study of LY3022855 In Participants With Breast or Prostate Cancer May 2015 October 4, 2017
NCT01798108 Completed Phase 1 Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases August 14, 2001 June 25, 2003
NCT02221882 Completed Phase 1 A Study of LY3164530 in Participants With Cancer August 2014 March 7, 2017
NCT02124148 Completed Phase 1 A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer June 18, 2014 February 13, 2020
NCT01851213 Completed FoundationOne™ Test Registry Study March 2013 March 2016
NCT02117648 Completed Phase 1 A Study of LY2835219 in Participants With Cancer April 2014 August 2015
NCT02107664 Completed The Palliative Radiotherapy And Inflammation Study - PRAIS December 2013 December 2018
NCT01919398 Completed Phase 1 A Study of LY2940680 in Japanese Participants With Advanced Cancers August 2013 June 28, 2017
NCT01933789 Completed N/A Improving Communication About Serious Illness September 2013 December 2016
NCT01957787 Completed N/A Study of Cryoablation for Metastatic Lung Tumors April 10, 2014 August 20, 2018
NCT02082886 Completed HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry February 2014 January 2020
NCT00701168 No longer available Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer
NCT06460961 Not yet recruiting Phase 1 A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001) July 15, 2024 July 13, 2029
NCT06395090 Not yet recruiting Phase 1/Phase 2 A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01) July 5, 2024 June 30, 2029
NCT03129412 Recruiting Phase 2 Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions April 14, 2017 April 23, 2025
NCT05596760 Recruiting N/A Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers September 11, 2023 July 2027
NCT05573893 Recruiting PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan September 12, 2023 December 31, 2030
NCT03797391 Recruiting Phase 1/Phase 2 A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors December 13, 2018 January 15, 2026
NCT00781612 Recruiting Phase 2 A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies October 16, 2008 September 20, 2029
NCT04307914 Recruiting N/A Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases March 10, 2020 June 1, 2026
NCT06119581 Recruiting Phase 3 A Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C December 21, 2023 October 2029
NCT04790968 Recruiting N/A Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients April 28, 2021 June 2024
NCT04886804 Recruiting Phase 1 A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) June 22, 2021 December 31, 2027
NCT04975308 Recruiting Phase 3 A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer October 4, 2021 August 31, 2027
NCT06046131 Recruiting N/A Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. February 28, 2023 February 28, 2039
NCT05023772 Recruiting N/A Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases September 2, 2021 September 2025
NCT05138094 Recruiting N/A LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection August 6, 2021 September 1, 2024
NCT05176665 Recruiting Phase 1/Phase 2 EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers October 21, 2021 August 31, 2024
NCT05244382 Recruiting N/A Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone Metastases February 7, 2022 June 2025
NCT05440786 Recruiting Phase 2 CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma September 20, 2022 September 10, 2028
NCT06018142 Recruiting Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors June 1, 2022 February 28, 2025
NCT05614739 Recruiting Phase 1 A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 January 12, 2023 June 2025
NCT05939960 Recruiting Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant Tumors July 1, 2023 September 30, 2024
NCT02138721 Recruiting N/A Local Treatment With RP for Newly-diagnosed mPCa June 28, 2018 December 31, 2024
NCT05648240 Recruiting Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients With Versus Without Intestinal Polyps February 23, 2023 February 2025
NCT03416959 Recruiting Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long Bones January 1, 2018 December 31, 2027
NCT03694015 Recruiting N/A SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases December 2, 2019 June 2024
NCT01499160 Terminated Phase 2 Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer May 2012 December 2016
NCT00281528 Terminated Phase 2 Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer February 1, 2006 March 1, 2011
NCT01441115 Terminated Phase 1 ECI301 and Radiation for Advanced or Metastatic Cancer September 6, 2011 April 24, 2013
NCT03166631 Terminated Phase 1 A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread September 8, 2017 October 28, 2020
NCT01846429 Terminated Phase 1 Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain September 2013 May 2015
NCT00023166 Terminated Phase 1 Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas May 2001 May 2002
NCT00099177 Terminated Phase 3 A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain August 2005 December 2007
NCT02353000 Terminated N/A Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases July 2016 December 2019
NCT00083993 Terminated Phase 3 Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer May 2004 October 2006
NCT02571530 Terminated Phase 1 Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer August 2015 June 2021
NCT02014116 Terminated Phase 1 A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body November 26, 2013 October 5, 2018
NCT00037180 Terminated Phase 2 For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy April 2002 January 2003
NCT02866344 Terminated N/A Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases August 2016 February 2018
NCT00327093 Terminated Phase 4 Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases May 2006 October 2008
NCT02167633 Terminated N/A Stereotactic Radiosurgery in Metastatic Spinal Cord Compression July 2014 September 2016
NCT00629187 Terminated Phase 1 Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy April 2004 April 2012
NCT00001880 Terminated Phase 2 Stem Cell Transplantation for Metastatic Solid Tumors March 12, 1999 August 13, 2020
NCT01649453 Terminated A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test May 2012 February 2013
NCT01118975 Terminated Phase 1/Phase 2 GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers March 2010 October 2012
NCT00602745 Terminated Phase 3 S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen February 2008 March 2010
NCT00130494 Terminated Phase 3 Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions August 29, 2002 October 22, 2007
NCT00127387 Terminated Phase 2/Phase 3 Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia May 2001 November 2005
NCT00908024 Terminated Phase 1/Phase 2 Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors October 2009 December 2012
NCT03986593 Terminated N/A Cryoablation of Bone Metastases From Endocrine Tumors September 26, 2019 May 29, 2023
NCT04135352 Terminated Phase 1 A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies (V938-001) November 4, 2019 August 24, 2022
NCT00377780 Terminated Phase 2 Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer August 2006 August 2015
NCT00121420 Terminated Phase 2 Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
NCT00120172 Terminated Phase 2 Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer May 2005 June 2006
NCT02313012 Terminated Phase 1 Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors January 5, 2015 May 3, 2016
NCT02376699 Terminated Phase 1 Safety Study of SEA-CD40 in Cancer Patients February 28, 2015 April 14, 2023
NCT00116389 Terminated Phase 2 Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
NCT01855061 Terminated Biomarker Development for Response Prediction by DNA Mutational Analysis May 2011 August 2016
NCT02835352 Terminated N/A Essential Oils on Anxiety of Patients Suffering From Cancer June 21, 2016 May 1, 2017
NCT04521621 Terminated Phase 1/Phase 2 A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013) October 28, 2020 July 25, 2023
NCT00102895 Terminated Phase 2 A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer April 2005 September 2005
NCT00099203 Terminated Phase 3 A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease July 2005 December 2007
NCT04763135 Terminated Phase 3 Mirtazapine in Cancer-related Poly-symptomatology December 15, 2021 December 17, 2021
NCT03881306 Unknown status Phase 1/Phase 2 DEBOXA for Inoperable NET Liver Metastases July 1, 2018 December 31, 2021
NCT01960829 Unknown status Phase 2 Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study September 2013
NCT01917279 Unknown status Phase 3 Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC October 2013 July 2021
NCT02208804 Unknown status Phase 2/Phase 3 Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization November 2014
NCT01823003 Unknown status Phase 2 Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases June 2012 July 2020
NCT02228356 Unknown status Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer June 2012
NCT01782287 Unknown status Phase 2/Phase 3 Proteome-based Immunotherapy of Lung Cancer Brain Metastases December 2012 December 2020
NCT02342158 Unknown status N/A Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors November 12, 2014 November 2022
NCT02352571 Unknown status Phase 1 Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer January 2015 June 2017
NCT01782274 Unknown status Phase 2/Phase 3 Proteome-based Immunotherapy of Brain Metastases From Breast Cancer December 2012 December 2020
NCT02395224 Unknown status A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway September 2014 January 15, 2023
NCT02408835 Unknown status N/A Negative Pressure Wound Therapy in Groin Dissection July 2015 July 2019
NCT01564810 Unknown status Phase 4 Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer September 2006 September 2015
NCT02495532 Unknown status N/A Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer March 2015 March 2018
NCT01489787 Unknown status N/A Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases March 2010 December 2019
NCT01442324 Unknown status N/A Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma February 2011
NCT00781209 Unknown status Phase 2 The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases October 2008 December 2010
NCT02882659 Unknown status Phase 1 Dendritic Killer Cell-based Immunotherapy for Solid Tumors August 2014 December 2017
NCT02934594 Unknown status Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate October 2016 August 2020
NCT00598845 Unknown status Molecular Markers in Treatment in Endometrial Cancer April 2001 December 2017
NCT00561522 Unknown status Phase 2/Phase 3 Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection November 2007 July 2012
NCT03113318 Unknown status N/A Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer October 2015 October 2022
NCT03175146 Unknown status N/A A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely September 2017 January 2021
NCT03223142 Unknown status N/A Standardization of Multi-modal Tumor Ablation Therapy System July 2017 July 2020
NCT00454519 Unknown status Phase 2 Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis March 2007
NCT03303495 Unknown status Phase 3 A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC November 14, 2011 December 31, 2018
NCT00433927 Unknown status Phase 3 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC) January 2007 December 2016
NCT00268684 Unknown status Phase 3 Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC May 2005
NCT03765190 Unknown status Phase 1/Phase 2 Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer January 1, 2019 December 1, 2022
NCT00133913 Unknown status Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer March 2004 January 2009
NCT01972503 Unknown status Phase 4 Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer June 2008 September 2015
NCT00122291 Unknown status Phase 2 A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer January 2002
NCT04308356 Unknown status Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status? June 3, 2020 June 2022
NCT04369872 Unknown status Phase 1/Phase 2 Microwave Ablation of Primary and Secondary Lung Malignancies May 1, 2020 December 31, 2022
NCT00116363 Unknown status Phase 2 Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma March 2005 December 2006
NCT04989192 Unknown status N/A Dose Efficiency of Modern CT Scanners in Oncologic Scans August 17, 2021 August 17, 2023
NCT05322486 Unknown status Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases October 29, 2020 December 2022
NCT05060653 Withdrawn N/A Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal Metastases October 2022 November 2023
NCT00149032 Withdrawn Phase 2 Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host August 2001
NCT00184288 Withdrawn Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. November 2004 December 2010
NCT05600582 Withdrawn Phase 1 A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer January 15, 2023 January 30, 2025
NCT00247403 Withdrawn Phase 1 Safety Study of 2DG With Stereotactic Radiosurgery October 2005 June 2008
NCT00346099 Withdrawn Phase 2 Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum June 2006 May 2007
NCT00478270 Withdrawn Phase 2 A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. June 2007 February 2008
NCT03029416 Withdrawn Phase 2 Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension October 26, 2017 August 9, 2018
NCT02839694 Withdrawn Phase 1 Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy July 7, 2016 April 26, 2017
NCT06057636 Withdrawn N/A Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study September 8, 2023 May 8, 2024
NCT00718055 Withdrawn Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients November 2006
NCT01178151 Withdrawn Phase 2 Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome October 2010 April 2015
NCT01461252 Withdrawn Phase 1 Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases April 2013 March 2014
MeSH unique ID (MeSH (Medical Subject Headings))
D009362